VSTM
Verastem, Inc.
There isn't enough reported data to score VSTM yet.
VSTM Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
VSTM's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
VSTM PE Valuation
VSTM has no meaningful PE right now: it lost money over the past year.
VSTM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect VSTM's losses to grow, with revenue growing.
VSTM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$3.90 | +$0.14 |
| Q2 2024 | -$4.05 | +$0.32 |
| Q1 2024 | -$5.11 | -$0.67 |
| Q4 2023 | -$4.81 | -$0.25 |
| Q3 2023 | -$4.04 | +$0.64 |
| Q2 2023 | -$4.37 | +$0.79 |
| Q1 2023 | -$4.44 | +$0.48 |
| Q4 2022 | -$4.56 | +$0.36 |
VSTM is still losing money, but far less than before: $2.00 per share over the past year, against $24.12 at its worst in late 2019.
VSTM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24M | +114% |
| Q2 2026 | $40.1M | +1775% |
| Q2 2025 | $2.1M | -79% |
| Q1 2022 | $2.6M | +158% |
| Q4 2021 | $545K | +7.7% |
| Q3 2021 | $2K | -100% |
| Q2 2021 | $500K | -88% |
| Q1 2021 | $1M | -80% |
VSTM's revenue is recovering but still below its 2020 peak: $24M last quarter, up 114% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -313% | +49 points |
| Q2 2026 | -82% | +1966 points |
| Q1 2026 | -240% | N/A |
| Q4 2025 | -237% | N/A |
| Q3 2025 | -362% | N/A |
| Q2 2025 | -2048% | -1865 points |
| Q2 2024 | -183% | N/A |
| Q1 2022 | -654% | +748 points |
VSTM's operating margin was −313% last quarter, up 49 points from the same quarter a year ago.
VSTM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2024 | -$23.8M | -$7.2M |
| Q1 2024 | -$28.3M | -$8M |
| Q4 2021 | -$9.9M | +$11.8M |
| Q3 2021 | -$10.8M | -124% |
| Q1 2021 | -$19.5M | +$14.5M |
| Q4 2020 | -$21.7M | +$15.5M |
VSTM has burned cash in almost every quarter: −$155M over the past year, against −$89M the year before.
VSTM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.1% | +1.1M shares |
| 1 year | +37% | +27.2M shares |
| 3 years | +505% | +84.5M shares |
| 5 years | +615% | +87.1M shares |
| Available history | +1492% | +94.9M shares |
VSTM has 101M diluted shares, up 37% from a year ago.
VSTM Net Leverage
VSTM's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
VSTM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.0 | Neutral |
| Stochastic | 67.9 | Neutral |
VSTM's weekly RSI is 58 (neutral) and its Stochastic is 68 (neutral).
VSTM PE vs Healthcare Sector
VSTM has no meaningful PE right now: it lost money over the past year.
VSTM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.64 | 2.3% below |
| 20 week MA | $7.37 | 15% above |
| 50 week MA | $6.54 | 29% above |
| 100 week MA | $6.76 | 25% above |
| 200 week MA | $6.95 | 21% above |
VSTM has slipped below its 8-week average, but it's still above the other four, and 21% above its 200-week average.
VSTM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.8 | $27.6 | +64% |
| 2021 | $27.6 | $27.7 | +0.4% |
| 2022 | $27.7 | $4.08 | -85% |
| 2023 | $4.08 | $8.14 | +100% |
| 2024 | $8.14 | $3.71 | -54% |
| 2025 | $3.71 | $8.06 | +117% |
| 2026 YTD | $8.06 | $8.44 | +4.7% |
VSTM's yearly returns have swung widely, from +117% in 2025 to −85% in 2022. It's up 4.7% so far in 2026.